Q3 2025 Leonardo DRS Inc Earnings Call
Speaker #1: Ladies and gentlemen , good day and welcome to the Leonardo Doctors . Third quarter Fiscal Year 2025 earnings Conference call . At this time , all participants are in a listen only mode .
Speaker #1: Following the company's prepared remarks , there will be an opportunity to ask questions and instructions will be given at that time . As a reminder , this event is being recorded .
Speaker #1: I would now like to turn the conference over to Steve Attar , Senior Vice President of Investor Relations and Corporate Finance . Please go ahead .
Speaker #2: Good morning, and thanks for participating in today's quarterly earnings conference call. Joining me today are Bill Lynn, our Chairman and CEO.
Speaker #2: John Rooney . Our CEO and incoming CEO . And Michael Dippold , our CFO will discuss our strategy , operational highlights , financial results and forward outlook .
Speaker #2: Today's call is being webcast on the Investor Relations portion of the website , where you will also find the earnings release and supplemental presentation .
Speaker #2: Management may make forward-looking statements during the call regarding future events, anticipated future trends, and the anticipated future performance of the company.
Speaker #2: We caution you that such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict . Actual results may differ materially from those projected in the forward looking statements , due to a variety of factors .
Speaker #2: For a full discussion of these risk factors , please refer to our latest form 10-K and our other SEC filings . We undertake no obligation to update any forward looking statements made on this call .
Speaker #2: During this call, management will also discuss non-GAAP financial measures, which we believe provide useful information for investors. These non-GAAP measures should not be evaluated in isolation or as a substitute for GAAP performance measures.
Speaker #2: You can find a reconciliation of the non-GAAP measures discussed on this call in our earnings release. At this time, I'll turn the call over to Bill.
Speaker #2: Bill . Thanks , Steve .
Speaker #3: Good morning and welcome everyone to the doctors Q3 earnings call . We continue to perform well . Our third quarter results demonstrate dockers close alignment with customer priorities , which was clearly reflected in our strong bookings , revenue and profit growth , as well as solid cash flow generation .
Speaker #3: As I told you last call, we expected second half bookings strength, and that materialized in spades in the third quarter.
Speaker #3: We secured $1.3 billion of bookings in the quarter , resulting in a 1.4 book to bill ratio . Our year to date book to bill ratio sits at 1.2 , and we continue to see a solid path to remain above one for the full year this quarter .
Speaker #3: Demand was most evident for our counter UAS advanced Infrared Sensing Naval Network Computing and Electric electric Power and Propulsion technologies . Our exceptional bookings propelled us to another record total backlog , which now sits at $8.9 billion , up 8% year over year , and also up sequentially .
Speaker #3: Funded backlog also saw remarkable year over year growth of 20% in the quarter . Diving deeper into our quarterly financial performance across metrics , we sustained double digit growth in the year to date , including in Q3 .
Speaker #3: This provides greater visibility to close out the year on a strong footing . Furthermore , the foundation built in the year to date leads us to increase our full year revenue growth expectations to 10 to 11% .
Speaker #3: Our profit metrics also showed strong performance. Adjusted EBITDA was up 17%, although margin slightly lagged behind prior year levels. As we continue to ramp our investment in internal research and development.
Speaker #3: Adjusted diluted EPs increased by 21% . Lastly , free cash flow significantly surpassed prior year levels , reflecting improved collection , linearity and working capital efficiency .
Speaker #3: In aggregate , our strong Q3 results place us in a solid position to meet our full year outlook . However , we continue to operate in a dynamic market environment and are focused on smoothly navigating it's complexities .
Speaker #3: The team and I remain focused on execution, discipline, and maintaining investment to sustain strong organic growth. While doctors continue to perform well.
Speaker #3: The operating environment offers both opportunities and challenges. Global threats persist, leading to continued growth in U.S. and allied defense investments to expand and enhance capabilities to deter and contest these adversaries.
Speaker #3: We are thankful that earlier this month, the remaining Israeli hostages were returned and that initial steps toward peace are being made in the Middle East.
Speaker #3: We are hopeful that the ceasefire sustains and brings lasting stability, not only for our employees in the region, but for all situated there.
Speaker #3: Domestically , the federal government remains shut down , marking the longest full shutdown on record . Unlike the last lengthy government shutdown in late 2018 , all agencies , including the Department of Defense , are impacted .
Speaker #3: Thankfully, to date, we have not seen a meaningful impact on our ability to execute our programs or deliver for our customers.
Speaker #3: However, as the shutdown extends, we are keeping a watchful eye on any impacts. We are hopeful that Congress and the administration negotiate and enact funding to provide clarity and visibility to our national security customers.
Speaker #3: Zooming out and taking a look at the bigger picture . Doctors remains well positioned in areas of customer priority , with strong alignment to enduring themes of counter UAS , improving shipbuilding throughput via industrial based expansion , enhancing missile production and sensing , and electronics modernization .
Speaker #3: There are clear funding tailwinds in the $150 billion for defense embedded in the tax reconciliation passed earlier this year . We are eager to see the enacted funding start to flow to our customers .
Speaker #3: Shifting to the supply chain, we are executing the strategy laid out last quarter to strengthen our germanium supply chain. We have begun recycling initiatives and are seeing early success in extracting adequate levels of germanium.
Speaker #3: We are also actively working on strategic agreements with several partners to ensure a consistent supply in 2026. Overall, I'm pleased with the progress made to date.
Speaker #3: There's still work to be done before resolving this constraint fully, but I am confident that the initiatives that we have put in place will successfully resolve this challenge in 2026.
Speaker #3: Let me wrap up my remarks with a few closing thoughts . Our year to date results reflect the resilience of our business and the strength of our differentiated technology portfolio .
Speaker #3: Customer demand is clear for our capabilities, and we remain focused on executing with excellence to support them in their most critical missions.
Speaker #3: The team has performed remarkably their commitment is unwavering and their incredible contributions are foundational to our financial success . Earlier today , I announced that I will be retiring as chairman and CEO on January 1st and our COO , John Balloony , has been named the company's new CEO .
Speaker #3: I've had the distinct privilege of leading doctors as CEO since 2012. The doctors we have today are unmistakably better and stronger than the ones I joined 14 years ago.
Speaker #3: I could not be prouder of what the team and I have accomplished together . We have strategically transformed doctors through a steadfast focus on reshaping the portfolio into enduring areas of demand , driving consistent innovation and executing to provide exceptional capability into the hands of our warfighters .
Speaker #3: All of these strategic actions have resulted in a consistently growing business with expanding profitability and strong cash generation. I am pleased with where the company is positioned today and the incredible potential ahead of it.
Speaker #3: This inflection point offers an opportunity for me to hand the reins over to someone who has been my right hand for nearly a decade.
Speaker #3: While I'm delighted with what we have achieved, I have high expectations for what this company will achieve under John's leadership as our next CEO.
Speaker #3: Many of you already know John . He's an outstanding leader in his absolutely the right person to take this on . He has a wealth of knowledge , deep technological expertise and vast experience at doctors , spanning over 35 years with significant operational impacts .
Speaker #3: Equally important, he possesses a profound understanding of our customers and their needs, coupled with an unwavering commitment to driving innovation and delivering solutions that ensure their mission success.
Speaker #3: Separately , the board is unanimously elected . Fran Townsend , our current lead independent director , to become chair . She has been a steady hand on our board , dating back to our acquisition by Leonardo .
Speaker #3: As part of this transition process , John , Mike , Steve and I will have several opportunities to meet with many of you over the coming months .
Speaker #3: John and I will be sharply focused on ensuring a seamless transition through the end of the year. Congratulations, John. Now let me turn the call over to him so he can review our operational highlights.
Speaker #3: Thank you . Bill . First , on behalf of all of our employees , I want to thank you .
Speaker #2: For your extraordinary leadership .
Speaker #3: And the incredible impact you've had on.
Speaker #4: I am honored to be the next CEO of Leonardo DRS, and I appreciate the trust you and the board have placed in me to lead this exceptional organization.
Speaker #4: I am very excited about where DRS is today. More importantly, I am enthusiastic about where we can take this company moving forward. The opportunities to create value for both our customers and shareholders are abundant as ever.
Speaker #4: Let me now turn to discuss key business highlights from the quarter. As Bill mentioned earlier, we continue to see a vigorous appetite for our counter-UAS solutions due to evolving threats.
Speaker #4: We are constantly iterating our offerings to stay ahead of the threat. Earlier this month, at the AUSA Annual Meeting, we showcased our leading expertise in counter UAS.
Speaker #4: We demonstrated our ability to develop and integrate a palletized mission equipment package that is vehicle and platform agnostic and applicable to both manned and unmanned systems .
Speaker #4: Furthermore , we successfully combined both short range air defense and counter UAS missions into a significantly smaller and lighter platform that JLTV in a growing field of counter UAS solutions .
Speaker #4: DRS stands out due to its reputation for bringing best of breed technologies well ahead of others and with proven field tested results in mission effectiveness .
Speaker #4: To that end , I would like to commend the team for taking first place at a recent Army counter . UAS competition , showcasing our cutting edge electronic warfare capabilities to disrupt drone threats .
Speaker #4: Additionally , in Q3 , we demonstrated cross success and in solving some of the hardest problems facing our armed forces , integrating our sensors to enable threat neutralization through a platform to platform kinetic kill handoff .
Speaker #4: Our leadership position in counter was has translated into demand across our portfolio , including our integrated systems and sensing solutions , and tactical radar electronic warfare and infrared .
Speaker #4: I want to highlight that in the quarter, we were awarded over $250 million in contracts for our premier ground counter UAS and short-range air defense programs.
Speaker #4: Moving to sensing, we continue to see strong demand building in the missile domain. We are actively engaged in initiatives to expand sensing capacity and bring generational upgrades to sensing content on new platforms.
Speaker #4: Additionally , unmanned systems present a growing , a growing area of opportunity for our multimodal sensing business as we integrate our technologies into both unmanned aerial and surface vessel platforms .
Speaker #4: Lastly, in our core infrared business, we continue to capture an outsized share of the market to supply our customers with infrared capabilities for dismounted and ground combat vehicle applications.
Speaker #4: Next , I want to highlight our new software offering , Sage Core . Sage core is an integrated operating system that brings AI advanced sensor and edge computing together in a single deployable solution for use on tactical platforms across multi-domain environments .
Speaker #4: Sage core is one piece of the innovation we are bringing to the next generation computing and sensor fusion . In the quarter , we also released Thor , a four plus one multifunction network computing product with the ability to host electronic warfare on crypto and tactical Wi-Fi capabilities .
Speaker #4: Thor complements the AI processor we developed earlier this year and supports the Army's next generation C2 initiative with a zero trust , cost effective solution for tactical and ruggedized computing at the edge .
Speaker #4: Additionally, we continue to see steady demand for our next-generation naval network computing solutions in support of the Navy's network sensor and integrated fire control initiative.
Speaker #4: Cooperative engagement capability , or CEC . Last , but certainly not least , I want to commend our electric power and propulsion business for the consistent and remarkable performance , the impact of their strong execution is evident not only at the segment level , but also at the company level .
Speaker #4: We continue to see this part of our business driving significant growth and margin expansion . We are well positioned to capture incremental scope and remain active in active conversations with our customers and industrial base expansion , particularly steam turbine generators .
Speaker #4: The growth opportunity of proliferating our electric power and propulsion technology into future platforms remains an exciting growth factor. Let me now turn the call over to Mike, who will review our third quarter and our revised 2025 guidance in greater detail.
Speaker #4: Thanks, John, and.
Speaker #5: Congratulations . I look forward to working closely with you in your new role to create value for our customers and shareholders . Bill , it's been a heck of a ride , and I'd like to thank you for your outstanding leadership .
Speaker #5: Overall , I'm pleased with our solid year to date performance , particularly amidst a complex and dynamic operating environment . Our third quarter reflects the results of our sustained focus on driving innovation process and customer demand into revenue growth and maintaining disciplined execution .
Speaker #5: Let me start by discussing our Q3 performance. Quarterly revenue grew by 18% over the prior year, totaling $960 million. The team did an impressive job converting strong customer demand.
Speaker #5: We also benefited from favorable timing of material receipts , resulting in revenue above the framework laid out on the Q2 call . From a segment perspective , IMS was our growth engine .
Speaker #5: IMS quarterly revenue was up 34% , driven by strong contributions from counter UAS and electric Power and propulsion programs . ASC demonstrated a healthy upper single digit increase 9% thanks to growth from Naval Network Computing , advanced infrared sensing , and Tactical radar programs .
Speaker #5: Shifting to adjusted EBITDA , Q3 adjusted EBITDA was 117 million , up 17% from last year . Quarterly adjusted EBITDA margin was 12.2% , reflecting a ten basis point margin contraction from the prior year .
Speaker #5: Higher volume and improved electric power propulsion program profitability were offset by increased research and development investments, less favorable program mix, and less efficient program execution, leading to the slight margin decrease in the quarter.
Speaker #5: Shifting to the segment view, ASC adjusted EBITDA was flat on a dollar basis but saw a 100 basis point contraction due to greater internal research and development investment, along with a less favorable program mix.
Speaker #5: IMS adjusted EBITDA was up 47% , with margin expanding by 120 basis points thanks to higher volume and improved profitability on our Columbia class program .
Speaker #5: On to the bottom line metrics . Third quarter net earnings were $72 million and diluted EPs was $0.26 a share , up 26% and 24% , respectively .
Speaker #5: Our adjusted net earnings at $78 million and adjusted diluted EPs of $0.29 a share , were up 22% and 21% , respectively . The favorable year over year compares were driven primarily by operationally led profit growth , coupled with slightly lower interest expense .
Speaker #5: Now on to free cash flow . Free cash flow was $77 million for the quarter , up significantly over the prior year despite increased capital expenditure , investment driven by increased net profitability and better working capital efficiency .
Speaker #5: With one quarter remaining , we are revising our full year 2020 guidance to incorporate our strong year to date performance , along with factors we expect to influence the business as we close out the year .
Speaker #5: We now expect revenue in the range of 3.55 to 3.6 billion , implying 10 to 11% year over year growth . Our backlog position provides clarity into the execution range .
Speaker #5: The single most important factor driving the output is the variability in the timing and level of material receipts received by year end . I would resist the urge to fixate on the implied fourth quarter trends over the past few years , we have steadily worked to improve quarterly linearity , and our year to date performance .
Speaker #5: This year is certainly reflective of that initiative . We expect Q4 to reflect comparable patterns , as last year , where there is a step down in growth from the first nine months of the year .
Speaker #5: Lastly , the nature of our business makes it challenging to run rate quarterly performance into any useful trend . Bottom line . The step down in implied growth to close the year should not be used as a read through for next year .
Speaker #5: Just as Q4 2024 was not indicative of the growth we are currently on track to deliver for 2025 . Next , we are maintaining the range of adjusted EBITDA .
Speaker #5: As a reminder , the range is between 437 and 453 million , as evidenced by our year to date results . We continue to expect IMS to be the source of the vast majority of profit and margin expansion for the year .
Speaker #5: Adjusted EBITDA margin at the company level continues to be constrained by increased R&D investment , less favorable program mix , and less efficient program execution , including the impact of germanium , the increased adjusted diluted EPs range incorporates a slightly lower effective tax rate .
Speaker #5: We now expect adjusted diluted EPs between $1.10 and $1.12 a share . Our revised tax rate assumption for the year is 18% , and our other non-operational assumptions remain static from our prior guidance .
Speaker #5: Lastly , with respect to free cash flow conversion , we are still targeting approximately 80% conversion of adjusted net earnings for the full year .
Speaker #5: Shifting to 2026 , we are in the middle of our normal course budgeting process . It's premature to provide specific guidance for next year , but as a team , we are focused on driving continued organic growth and expanding adjusted EBITDA margin consistent with past practice .
Speaker #5: We plan to provide formal guidance in conjunction with our fourth quarter and fiscal year 2025 call in late February . In conclusion , I want to thank the team for their incredible contributions in bringing innovation to solve complex national security challenges , delivering exceptional technologies to our customer , and delivering solid financial results for our investors .
Speaker #5: We will continue to remain focused on rigorously executing our strategy to create value through durable , long term growth . With that , we are ready to take your questions .
Speaker #1: Thank you . If you would like to ask a question , please press star one on your telephone . You will then hear an automated message advising your hand is raised .
Speaker #1: If you would like to remove yourself , press star one again . We also ask that you please wait for your name and company to be announced before proceeding with your question .
Speaker #1: One moment while we compile the Q&A roster. The first question today will be coming from the line of Peter Amit of Baird.
Speaker #1: Please go ahead .
Speaker #6: Yeah . Good morning and congrats , Bill and John . Bill , thanks for all the support over the years . Really appreciate it .
Speaker #6: Peter . Hey , question on on just our ad spending . Obviously you're seeing a lot of opportunities up pretty significantly 35% . I think in 2025 .
Speaker #6: How do we expect that trending . Just because of kind of some of the margin performance we've seen at ASC , just because some of that is impacting that ?
Speaker #6: How does that trend as we go forward?
Speaker #5: I would expect to see this internal research and development investment kind of stay at this percentage of revenues. I think we're in a more dynamic operating environment where the procurement process has changed from the department.
Speaker #5: And I think that we're going to continue these investment levels to provide that agility in order to maintain this growth . Peter .
Speaker #6: Okay . So that was roughly like mid 3% or so , roughly , or right around there . Yeah ,
Speaker #5: Give or take around there . Yep , yep .
Speaker #6: Okay okay . Helpful . And then just I guess any updates on just kind of foreign military sales activity . Obviously there's a lot of demand signals from Europe .
Speaker #6: You guys are well positioned . What are you seeing there , Bill . And any opportunities for you know for doctors .
Speaker #3: Yeah thanks , Peter . We do think we're going to see a ramp up in foreign military sales opportunity . We're just at the I think at the start up for the force protection , the counter UAS .
Speaker #3: I think that has a real opportunity . We continue to see demand for our sensors . The sensors and for our network computing .
Speaker #3: And I think given the threat environment , we expect those to continue . And then we are working to develop markets for our naval power and propulsion system , particularly in Asia .
Speaker #6: Just one last question for me, regarding Mike and the germanium pricing as things have stabilized there. Have you secured more suppliers or lined up supply for next year?
Speaker #6: Thanks .
Speaker #5: Yeah , I'll take that out to start and then maybe hand it over to Bill . But first , on the pricing side , as we talked about in our last call , I think we've got 20 , 25 kind of lined out and there were no real surprises or anything from our last call on the germanium front .
Speaker #5: We are making some progress in terms of solidifying supply into 26 , and I'll hand it over to you , Bill . There .
Speaker #3: Yeah . As as Mike said , Peter , we're trying to build a structure that supports our revenue flow for optics going forward .
Speaker #3: And so that that involves in the near term . Recycling existing germanium from older optics over the the mid-term , we've moved to diversify our supply base with agreements with different suppliers and processors and basically you need to move it away from reliance on China .
Speaker #3: And we're we're seeing success in both those near-term and mid-term initiatives . And we we think that will put us in a strong position in 2026 .
Speaker #6: Thanks . I'll jump back in the queue . Thanks , guys .
Speaker #1: Thank you . And our next question will be coming from the line of Robert Stallard of Vertical Research . Your line is open .
Speaker #7: Good morning. Thank you very much.
Speaker #3: Good morning .
Speaker #4: Good morning .
Speaker #7: And best of luck , Bill and congratulations , John . First of all , to kick things off . Very good quarter for bookings .
Speaker #7: And I was wondering if there were any unusually large orders that were placed this quarter. In relation to that, how do you expect these bookings to flow through to revenues?
Speaker #5: Yeah , I would say there was an increase in demand that we saw on the counter . UAS and short range air defense programs .
Speaker #5: So those came in heavy for the quarter , which accelerated some of the bookings results , primarily in the IMF segment . So that was a little bit of a of a pop .
Speaker #5: There, and then we did see some accelerations just across the board as just the typical flow you see at the government fiscal year-end, September wrapped out.
Speaker #5: So a little bit plussed up that says , I look out for the year . I expect to be comfortably ahead of the , you know , that 1 to 1 target that we've put out there .
Speaker #5: We've got a good foundation for that. So, we expect the demand to continue and feel good about our bookings number for the year.
Speaker #5: In terms of of the revenue turn , you know , obviously for us it's about our funded backlog and how that pulls over into revenue bill mentioned in the in the prepared remarks here that the backlog was up 20% year over year .
Speaker #5: And if you look at it sequentially, it's up 7%. So we're feeling good about the foundation we have for 2026.
Speaker #5: Rob .
Speaker #7: Okay . And then as a follow up for Bill , you highlighted the extended US government shutdown . If this carries on , what sort of potential risks do you see for doctors from this situation ?
Speaker #3: Yeah , Rob it depends . For how long ? Of course we're anticipating , you know , at least going well into November .
Speaker #3: And as I said in the prepared remarks , the impact of that length is , is , is moderate as it starts to go longer than that , it's the people who who pay us and give us the awards aren't there .
Speaker #3: And so you'll start to see delays in awards and delay and pay . But it would it would really have to keep going for , you a longer period .
Speaker #3: Well, we're already basically longer than we've ever seen, but it would have to be a historic length before we'd see an impact.
Speaker #7: Okay . And then just one final one for Mike . You said there was some , I think , operating efficiency issues on programs in the quarter .
Speaker #7: You highlighted germanium . Is there anything else we should be aware of ?
Speaker #5: No , it's primarily germanium . Obviously , with our development programs , we always have a little lower margin when we have that mix .
Speaker #5: But in terms of the context of the comment, it centers around germanium.
Speaker #7: That's great. Thank you very much.
Speaker #1: Thank you. And our next question will be coming from the line of Mark of Michael, Ceremony of Truist Securities. Your line is open.
Speaker #8: Hey . Morning , guys . Thanks for taking the questions . Bill . John , congrats . And Bill , thanks for for everything over the years .
Speaker #8: Maybe just back to Peter's question on the margins. I mean, you guys had 26 targets out there. You've obviously got this elevated R&D.
Speaker #8: How do we think about , you know , the payback and measuring the return on this R&D ? Do we should we expect do we do we see new programs maybe an acceleration of revenue growth off of what you've done this year ?
Speaker #8: Just trying to get a sense of really measuring the payback on the R&D investments?
Speaker #5: Yeah, I think the payback on R&D investments is going to put us in a position to attack a lot of those adjacent markets and growth opportunities that we've had.
Speaker #5: So, I think as you think about the kind of new way of procurement and coming to the table with solutions that are already at a higher kind of technical maturity, that's what we're really doing here.
Speaker #5: I think it is giving us some good opportunities in the counter UAS domain. I think it's giving us some opportunities here as we look to kind of unmanned surface vessels.
Speaker #5: So all of these are giving us some , some additional opportunities to to continue the growth that we've seen . And that's really what we're expecting from the investments at these levels .
Speaker #5: Mike .
Speaker #8: Okay , okay . Is that you just mentioned counter UAS and we've heard it a couple times . Is there any way to sort of quantify or size your your exposure at this point to , to counter UAS programs ?
Speaker #8: And , you know , maybe size the pipeline of opportunities ? You know , you mentioned AUSA , you know , there's certainly , you know , a lot of competing companies from new entrants to , you know , large scale primes .
Speaker #8: Guys like yourselves , everybody's throwing around new offerings . I mean , can you give us any sense of , you know , where your revenues are today or what you think your growth rate is or sort of adoption penetration ?
Speaker #8: There ?
Speaker #5: Yeah . And I think this is one of the nice differentiators is when when we talk about counter UAS , that is largely all of our force protection type of revenue that we have there .
Speaker #5: So, we talk about and disclose force protection being about 20% of our revenues. That's largely dominated by the short-range air defense and counter-UAS program.
Speaker #5: So we have real penetration , which we believe gives us an advantage as we look to the future here . So that's think about that kind of in that 18 to 20% range of revenue is all tied to to those efforts .
Speaker #4: Let me let me add to that quickly . And just say that , you know , we're the the current provider . The provider for counter us for the US Army , our solutions are battlefield tested .
Speaker #4: We know that our solutions work and we're always adapting . Our solutions to the evolving threat . We did see a lot of counter UAS solutions on the AUSA floor , but we distinguish ourselves by having a battle proven capability , and we're very close to our customer .
Speaker #4: We understand what they need . We understand where they're thinking . We do expect that counter USA to kind of expand and proliferate to all echelons of the forces , and really all domains .
Speaker #4: And so we see a real opportunity in the future here as driving innovation and and pushing this out new , new technology .
Speaker #8: Okay . Would you say you're kind of equally exposed to both kinetic and kind of non-kinetic solutions for counter UAS ?
Speaker #4: Yeah , I would , I would say this , Michael , I think that you're going to see both capabilities on the battlefield that's going to depend on where you are in the echelon .
Speaker #4: If you're if you're up in the front , you know , next to the front , you're going to see some capabilities back in the in the back of the higher echelons .
Speaker #4: You're going to see other capabilities . D is going to end up probably at both . Both echelons . But those capabilities are going to be differing .
Speaker #4: So you're going to start seeing the counter us counter US market kind of proliferate across all echelons , all different capabilities . And we provide all of that .
Speaker #8: Okay okay . Last last quick one for me Mike . Just . Should we expect the same margin profile in 26 with with kind of ecms being the lead engine and some more of that Irad dampening down the ASC margins ?
Speaker #5: Yeah , I wouldn't expect the trends to continue . You know , we're not going to go deep into 26 here . But in terms of just the allocation of profit , the investment is going to stay heavy at ASC .
Speaker #5: And we still feel pretty good about the tailwind that is Columbia . As we look into into the future .
Speaker #8: Got it . Thanks , guys . I'll jump back in the queue .
Speaker #1: Thank you . And our next question will be coming from the line of Kristine Liwag of Morgan Stanley . Your line is open .
Speaker #9: Hey guys . Bill , congratulations on your retirement . It's been a pleasure to see how you've transformed doctors over the years . And congrats on your new role .
Speaker #9: I guess following up on the supply chain , you guys have called out germanium a few times , so I just wanted to dive a little bit deeper into this .
Speaker #9: Can you talk a little bit more about , you know , your your sourcing strategy for this ? Like how much inventory do you have ?
Speaker #9: It sounds like you got a little bit better . Access , but it would be really helpful to understand regarding some sort of timeline or some sort of quantity .
Speaker #3: Yeah . Thanks , Christine . I don't think I can give you a precise numbers , but let me give you kind of the approach we had before anticipating these kinds of issues .
Speaker #3: Bought a buffer stock , which is we are using to transition 25 and support our 25 flow through at the same time . We're now actively involved in recycling from over optics and pulling the extracting the germanium and constructing new new optics from that .
Speaker #3: And that's that's now we've seen success in that , that process . And that will bridge us into into 26 and get us partway through 26 .
Speaker #3: And then at the same time , we're involved in developing partnerships with companies in both the mining and the processing area outside of China , so that we have a long term supply .
Speaker #3: And that's what gives us confidence that we're going to have a robust 26 , and we're going to be able to support our germanium needs with these both mid , mid term and short term initiatives .
Speaker #9: Great . Thank you for that . And maybe pivoting to a different topic . I mean , in the quarter , you guys made a $15 million investment on hoverfly .
Speaker #9: I wanted you to know, I think you're now at 25% of your equity stake here. I wanted to better understand what your strategy is regarding, you know, these unmanned capabilities.
Speaker #9: Where does this fit into your broader portfolio and strategic vision ?
Speaker #5: Yeah , I would say the investment with hoverfly is really kind of key to to some of the strategy that we have in terms of making sure we're bringing the best in breed technologies to different solutions .
Speaker #5: We think this tethered capability is going to allow for obviously , for elevated sensing , for targeting , potentially for counter UAS . So there's there's some good applications here for this capability .
Speaker #5: And that's what what fostered the investment .
Speaker #9: Gotcha . Great . If I could do a follow up question , you know IMS growth was up 34% year over year , 32% up sequentially .
Speaker #9: Can you provide any color on how much of this was driven by the Columbia class ? And were there any other transitions in chipsets that drove this step up ?
Speaker #9: Thank you .
Speaker #5: I didn't catch what the first part of that question , Christine , I'm sorry .
Speaker #9: Oh , sorry . On IMS growth IMS was up 34% year over year , up 32% sequentially . Just trying to understand how much of this step up was driven by Columbia class , or if there were other transitions and chipsets that drove this increase .
Speaker #5: Yeah . So a good question . The the increase in the revenue actually , Columbia's been pretty stable from its revenue output in a quarterly cadence throughout the course of the year .
Speaker #5: The increase in revenue is really coming from a lot of the short range air defense and counter UAS programs for the quarter . So that's where the big pop was this quarter .
Speaker #9: Great . Thank you .
Speaker #1: Thank you . And as a reminder , please limit yourself to one question and one follow up . The next question will be coming from the line of Anthony Valentini of Goldman Sachs .
Speaker #1: Please go ahead .
Speaker #6: Hey guys . Thanks for taking .
Speaker #8: My question. And Bill, congrats on a great quarter.
Speaker #6: A great .
Speaker #10: Run . I'm just trying to get a sense for the longer term growth prospects here . Are there opportunities to take what you guys are doing in propulsion on Columbia to other types of ships and programs and the primes are talking about significant growth in missiles , which I think are highly dependent on the sensors .
Speaker #10: You guys have expertise there . So I'm wondering how large the missile business is today for doctors and where that can go over time .
Speaker #10: Any color really on the on the large growth vectors would be great . Thanks .
Speaker #4: Thanks , Anthony . This is John . Let me let me start with the ship and the propulsion systems . And absolutely we are looking and bidding other ship classes and we have some , some real progress in that regard shaping .
Speaker #4: We believe that we have an advantage in providing energy , flexibility on board a ship . It's not obvious , but the more energy , more , more power a ship has , the further away can fight .
Speaker #4: You know , for longer range radars , longer range electronic warfare , a longer range directed energy . And our solutions allow for that capability to be able to direct that energy to different places on the ship .
Speaker #4: So yes , for sure , we believe that there's opportunity , long term growth for us . There . Turning to missiles , doctors has always been a supplier of the best infrared sensing in the industry and other sensors as well .
Speaker #4: We're really at the top of the food chain when it comes to to missiles . Those missiles have to be smarter . They have to have longer range .
Speaker #4: They have to have greater capability . So we're seeing an increased pull for those higher performing sensors into that space . And so we're playing at all different from the very low cost , high volume missiles .
Speaker #4: And effectors all the way to the very high end missiles . And effectors .
Speaker #1: Thank you . One moment for the next question . And the next question will be coming from the line of Seth Seifman of JP Morgan .
Speaker #1: is open .
Speaker #11: Hey , thanks very much . Good morning , everyone , and congratulations to to Bill and to John as well . I wanted to ask John , you mentioned at the outset the sage core .
Speaker #11: I wonder if you could talk a little bit about how that fits into the Army's Nkx2 plans and , you know , the extent to which that can be can be a growth driver .
Speaker #11: It seems there's a good amount of funding headed in that direction.
Speaker #4: Thanks , Jeff . Let me let me step back and talk about the fact that when we see platforms , all platforms are going to end up having to think for themselves .
Speaker #4: I got to sense for this , for themselves and think for themselves . At the end of the day , those platforms that are at the edge of the battle space , whether it's land , sea or air , are going to have disrupted communications in battle .
Speaker #4: So those computing resources for those platforms have to think about what's happening on the battle space, and space has to be on the platform.
Speaker #4: It has to be at the edge . And so this is where we're putting our energy . This is where we're putting a lot of our money is to is to build out that capability .
Speaker #4: The connectivity from the platform up to the enterprise will be there at certain times . And some of the enterprise capabilities will will play there .
Speaker #4: But but those , those platforms have to think . So this is part of NGC two next generation of C2 program with the Army is being able to build out a capability on the platform , not just to to communicate , but also to think .
Speaker #4: And so we're adding the AI capability . And now with the Sage Corps , it's really the doctors operating system , which we're going to place onto those computing resources at the edge that allow those platforms to think for themselves , to fuse the sensing information , to have AI to understand what's going on on the edge , and to be able to to make sense and act on on the information .
Speaker #4: So that's where Sage Corps fits into the into the program , not just for for the Army's platforms , but we're we're also using it on the key for , for USV .
Speaker #4: We're also putting in other platforms in space as well.
Speaker #11: Excellent , excellent . Thanks . And as a follow up , if we could just talk about IMS and on the on the Columbia kind of what ship set you're up to or maybe a different way of saying it is , you know , how far up the curve are we in terms of when you've got kind of two a place where pricing is kind of stabilized ?
Speaker #5: Yeah . And we've talked about Columbia in the past , that we're always kind of working on three different chipsets simultaneously in terms of our revenue base .
Speaker #5: What happens in 2025 is we will start to pretty much retire the second chipset , which was bid at a lower price point .
Speaker #5: So subsequent to 2025 , we'll be at a cadence where all of the new ship and revenue base associated with the different ship classes will be negotiated after the design was was materially complete .
Speaker #5: After the inflation impacts to labor and materials . So we should see more consistent margin output from Columbia starting in 2026 with one more year of margin expansion .
Speaker #5: And then the little asterisks I put on that is that is , before we see the margin benefit from the South Carolina facility .
Speaker #5: And think about that impact starting in 2027 .
Speaker #11: Great , great . Thanks very much .
Speaker #1: Thank you . Our next question will be coming from the line of Andrea Madrid of Btig . Your line is open .
Speaker #12: Good morning , everybody , and congrats to Bill and John .
Speaker #4: Thank you . Thank you .
Speaker #12: I want to talk again about hoverfly . You know great to see the up investment . There . Is this something that fits into your previously outlined M&A criteria .
Speaker #5: Yeah I would say that when we're talking about M&A we're looking at different aspects of that , whether they're joint ventures , partnerships , minority investments , and certainly with this capability , having the ability to assist us in in elevated sensing to bring our sensors through from a network perspective .
Speaker #5: I think that this kind of checks the boxes that we were looking at from an M&A perspective , and it certainly strategic to where DRS is headed .
Speaker #12: Got it , got it . That's that's helpful . And then I wanted to follow up on the kuas work that you guys are doing .
Speaker #12: Could you maybe talk a bit more about the margin profile of that work . And if it's generally accretive or dilutive to IMS ?
Speaker #5: Yeah , we don't get into the to the marginality of of this particular program . But it's the same customer set . It's a , you know , in line with the rest of our portfolio .
Speaker #5: There's no anomalies here from a from a drag or from a tailwind perspective .
Speaker #12: Got it . Got it . I appreciate the color , Mike . And I'll leave it there .
Speaker #1: Thank you . And our next question will be coming from the line of Ronald Epstein of Bank of America . Your line is open .
Speaker #13: Hey , guys , this is Alex Preston on for Ron today . First of all , just wanted to echo the congratulations to both Bill and John .
Speaker #13: Thank you . I wanted to circle back on the government shutdown . You know obviously three Q bookings are really strong you guys mentioned there's not a ton of material impact at this point , but I'm wondering if you're seeing any slowness in the contracting environment and if so , where .
Speaker #13: You know , I think , for instance , we might have expected Golden Dome awards to be maybe a little more firmed up by now , given the reconciliation funding is to be spent .
Speaker #13: There's contract vehicles in place . I'm curious if you have any commentary on that .
Speaker #3: Yeah . As I said , it would take a while before this would catch up to influencing things like that . And it would through , you know , think of things like , you know , testing to prove systems out .
Speaker #3: But those schedules are generally pretty far out . And so we haven't really seen much more than modest impact yet . And it would have to go much closer to the end of the year before we'd see that .
Speaker #13: Okay . Thanks . And then just as a quick follow up , you know , we've noted a bunch of us have noted the strength in counter bookings and revenue this quarter .
Speaker #13: Just curious if you could characterize more on where the demand is coming from. I know you mentioned there's particular strength in the U.S. Army.
Speaker #13: There's foreign military sales involvement . Just curious if you could provide any color on the split there ?
Speaker #4: Yeah , I think that's where the demand is coming from for sure . We are seeing demand coming from really all over . We're seeing demand coming from the Army for sure , and that's that's evident in the bookings .
Speaker #4: We're seeing demand coming from the Navy and Marines, as well as the U.S. Air Force, which is also plagued with this problem. We're seeing progress there in demand building.
Speaker #4: And some bookings there as well . And of course , direct commercial and international FMS sales as well . This demand coming from all all avenues , as you might imagine , due to the due to the changing nature of warfare .
Speaker #13: Great . Thank you guys . Appreciate the help .
Speaker #1: Thank you . And our next question will be coming from the line of Jon . Of sea JS please go ahead .
Speaker #14: Hi . Good morning . Thank you for taking my questions and congratulations on your retirement . And and John and Fran on their appointments .
Speaker #14: My first question is if you could drill just a little bit more into the germanium supply , that would be helpful . You mentioned bridging , you know , into the future with the recycling .
Speaker #14: And then alternative supply . But do you expect to be constrained in the coming quarters as your stockpile falls off ? And then maybe catch up later in the year ?
Speaker #14: Or how do you expect that to shape up ? Does , you know , do the programs that you have in line fill 100% of the supply right out the gate , or does it take time to get there ?
Speaker #3: We think we have a plan , John , that that does bridge from the 25 , where I think we've taken account of the supply restrictions and price increases , and we we have it planned into 26 with the different initiatives that I mentioned .
Speaker #3: So, we're feeling comfortable as to where we are.
Speaker #14: Okay . Great . That's helpful . And then second is the price on these alternative supplies significantly higher than what you're seeing in the market .
Speaker #14: And does that further impact the ASC margin as we go forward ? How should we think about the profitability there ? As you ramp these alternative sources ?
Speaker #5: Yeah , I would say that as you know , we're we're largely a fixed price shop . So the higher pricing is certainly going to be , you know , inherent in those programs as we look into , into 2026 .
Speaker #14: Okay . Got it . One last one . If I could just any changes to thoughts on capital allocation . You obviously did the hoverfly investment .
Speaker #14: You did some share repurchases . But any thoughts on capital allocation and use of cash going forward ?
Speaker #3: Yeah , I mean as we've said that we want to have a balanced capital allocation strategy . So we've instituted a dividend this year .
Speaker #3: We have a moderate buyback , but our priority continues to be seeking out M&A opportunities that meet both our strategic and financial criteria , in that we've exercised patients .
Speaker #3: We've looked at a lot of things we are doing the hoverfly this this quarter is we mentioned we're looking at at larger investments as well .
Speaker #3: But you should expect going forward to see more M&A . But a balanced strategy as well .
Speaker #14: Great . Thank you and congrats again .
Speaker #1: Thank you . And our next question will be coming from the line of Austin Miller of Canaccord . Your line is open .
Speaker #15: Hi . Good morning . Thanks again , Bill and John for your leadership . Just my first question here . You've talked about recycling germanium from older optics .
Speaker #15: It sounds like you're going to get additional legs on your supply beyond Q1 26 , which is , I think what you discussed last time for your visibility .
Speaker #15: Have you looked into alternative glass-based solutions like Black Diamond Glass, potentially to replace the germanium, just given it has less temperature sensitivity and better supply?
Speaker #3: We we you're correct . We have we are looking at alternative materials . It's particularly relevant for smaller optics where you can replace germanium with other .
Speaker #3: And that is part of the portfolio of solutions . We're we're pursuing . And that that one is in the early stages . But we are seeing success there as well .
Speaker #15: Okay . And just to follow up , if we I know we're in a shutdown here , but if we think about the opportunity for Golden Dome and when we start to get RFPs and contracts for that , do you have any sense of of the timing next year ?
Speaker #15: And there's also like your partner AeroVironment has been testing counter UAS solutions at Grand Forks in North Dakota .
Speaker #4: Let me let me take the the Golden Dome part of that for sure . We're seeing a lot of activity on Golden Dome .
Speaker #4: While the the architecture is not yet public , we certainly see movement . You're probably aware of the the shield RFI , RFP that I think 1500 companies bid , including DRS .
Speaker #4: We do expect that to move forward very quickly . I think that we see we see opportunity here , not just in the the space sensing , but also in the underlayer and also on the over the radar area .
Speaker #4: So we believe that that's going to move forward and general guidelines moving forward very quickly on the counter . UAS front , we see a lot of activity in counter UAS , including handrails , activity .
Speaker #4: And I think that , you know , just to go back to the points about the fact that we are the ones that are solving this problem for the Army , we have battle proven technology .
Speaker #4: We've proven our capability , and we're following the threat , making sure that we're ahead of the threat and very close to the customer .
Speaker #15: Got it . Thanks for filling me in .
Speaker #1: Thank you . I would now like to turn the call over to management for closing remarks . Please go ahead .
Speaker #2: Thank you . Lisa , and thank you all for your time this morning and your interest in doctors . As usual , if you have any follow up questions , please call or email me .
Speaker #2: We look forward to speaking with all of you again soon . Enjoy the rest of your day .